Encouraged by these results, we performed an in vivo experiment applying a protocol of WBRT mimicking the clinical approach (Fig. 1b) to our preclinical model once lung cancer brain metastasis with downregulated S100A9 levels were established (Fig. 3a)53. The gene discussed is S100A9; the disease is lung carcinoma.